Bulletin
Investor Alert

Arcturus Therapeutics Holdings Inc.

NAS: ARCT

GO
/marketstate/country/us

After Hours

/zigman2/quotes/202272083/composite

$

50.61

Change

+1.36 +2.76%

Volume

Volume 468

Aug 11, 2020, 6:39 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202272083/composite

Today's close

$ 58.91

$ 49.25

Change

-9.66 -16.40%

Day low

Day high

$48.89

$57.43

Open
Open: 57.15

52 week low

52 week high

$8.51

$63.45

Open

Market cap

$1.41B

Average volume

874,159

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-2.54

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/arct

MarketWatch News on ARCT

  1. Arcturus Therapeutics started at outperform with $72 stock price target at Raymond James

    8:15 a.m. July 16, 2020

    - Tomi Kilgore

  2. Arcturus Therapeutics started at buy with $70 stock price target at B. Riley FBR

    8:35 a.m. July 13, 2020

    - Tomi Kilgore

  3. Biotech Arcturus Sees Stock Soar on Coronavirus Vaccine Pact

    11:36 a.m. March 4, 2020

    - Barron's Online

  4. How to Invest in MRNA Technology

    9:30 p.m. Aug. 30, 2019

    - Barron's Online

  5. Arcturus Therapeutics downgraded to neutral from buy at Ladenburg Thalmann

    9:57 a.m. Feb. 28, 2018

    - Tomi Kilgore

  6. Alcobra Ltd. stock plummets 43% after failed late-stage trial for its ADHD drug

    9:13 a.m. Jan. 17, 2017

    - Emma Court

  7. Alcobra upgraded to hold from sell at WBB Securities

    9:31 a.m. Nov. 2, 2016

    - Tomi Kilgore

  8. Alcobra downgraded to underweight from equal weight at Barclays

    11:50 a.m. Oct. 28, 2016

    - Tomi Kilgore

  9. Alcobra's stock plummets 61% premarket after IND put on hold late Wednesday

    7:54 a.m. Sept. 29, 2016

    - Tomi Kilgore

  10. Investors in health-care stocks get rich as M&A booms

    9:42 a.m. March 18, 2015

    - Philip van Doorn

  11. 10 stocks that are pushing the Nasdaq to 5,000

    6:48 p.m. Feb. 23, 2015

    - Philip van Doorn

Analyst Ratings

/news/nonmarketwatch/company/us/arct

Other News on ARCT

  1. Arcturus Therapeutics Holdings (ARCT) Investor Presentation - Slideshow

    3:28 p.m. Today

    - Seeking Alpha

  2. Raymond James Believes Arcturus Therapeutics (ARCT) Won’t Stop Here

    8:32 a.m. Today

    - SmarterAnalyst

  3. Arcturus Therapeutics (ARCT) Gets a Buy Rating from H.C. Wainwright

    6:31 a.m. Today

    - SmarterAnalyst

  4. 10-Q: ARCTURUS THERAPEUTICS HOLDINGS INC.

    5:04 p.m. Aug. 10, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  5. IPO Update: CureVac Readies Plans For U.S. IPO

    12:44 p.m. Aug. 10, 2020

    - Seeking Alpha

  6. CureVac Starts U.S. IPO Effort

    4:29 p.m. Aug. 6, 2020

    - Seeking Alpha

  7. 5 Biotech Stocks Set to Outpace Q2 Earnings Estimates

    9:57 a.m. Aug. 6, 2020

    - Zacks.com

  8. Arcturus Therapeutics prices $173M public offering

    6:09 a.m. July 29, 2020

    - Seeking Alpha

  9. Biotech Bonanza - Second Half Outlook

    8:24 a.m. July 28, 2020

    - Seeking Alpha

  10. Israel in talks to buy 4M doses of Arcturus COVID-19 vaccine

    3:15 p.m. July 23, 2020

    - Seeking Alpha

  11. Loading more headlines...
/news/pressrelease/company/us/arct

Press Releases on ARCT

  1. Arcturus Therapeutics to be Added to Russell 2000(R) Index

    8:00 a.m. June 29, 2020

    - GlobeNewswire

  2. Wednesday Sector Laggards: Biotechnology, Drugs

    12:06 p.m. May 27, 2020

    - MarketNewsVideo.com

  3. Month's Top Gainers: $CDEV $ARCT $PTLA

    2:59 p.m. May 19, 2020

    - The Market Signal

  4. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.